A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

Monday issued an epidemiological alert given the growing circulation of a different of dengue in the region. Cases of the ...

DHAKA, Feb 10, 2025 (BSS)- A total of 29 dengue patients were admitted to different hospitals in the country during the past ...

The Portuguese Ministry of Health has confirmed the presence of dengue in Madeira, raising concerns among residents and ...

A second subtype of H5 bird flu, known as D1.1, was detected in dairy cattle and infected one worker in the US state of ...

Cartagena, Colombia, has reported a substantial increase in dengue cases during the initial weeks of 2025. According to the ...

Home > Pressemitteilung: New study sheds light on the causes ...

It can be recalled that PhilHealth launched a total of thirteen (13) new and enhanced benefit packages in 2024. These include the benefit package for hemodialysis which increased to P6,350 for 156 ...

PAHO is tracking a rise in dengue serogroup 3 activity, which could raise the risk of severe illness as countries approach the peak of the season.

Canada gives the green light for visits to these destinations, advising travellers to take normal security precautions.